TGTX

TG Therapeutics, Inc. - Common Stock

$11.57 -$0.18 -1.51%


Own 4 of TGTX at $12.00

Shares Bought9
Shares Sold5
Total14
Shares Owned4
Last Price$11.57
Total Return-$0.16
Range Today$11.39 - $11.80
52 Week Range$4.10 - $15.35
Open$11.80
Market Cap$800.01M
Volume/Average154.33K/1.31M
P/E Ratio-
Dividend/Yield-




TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. It also involves developing TG-1101 and TGR-1202 therapies targeting hematological malignancies. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY.


Orders

Date Side Shares Price
08-08-2017 19:29:39 buy 1 $10.04
08-08-2017 19:44:59 buy 1 $10.14
08-08-2017 20:22:28 buy 1 $10.25
08-09-2017 15:03:02 buy 1 $10.39
08-10-2017 16:34:38 sell 1 $9.90
08-11-2017 15:08:24 sell 1 $10.76
08-18-2017 14:08:08 sell 1 $10.80
08-18-2017 14:14:32 sell 1 $10.86
08-28-2017 16:04:16 buy 1 $11.74
08-28-2017 16:07:50 buy 1 $11.74
08-29-2017 13:45:53 buy 1 $11.69
08-29-2017 22:00:17 buy 1 $12.14
08-31-2017 21:30:17 buy 1 $12.65
09-18-2017 13:54:24 sell 1 $12.01